Background: Fast post-implantation stent endothelialization is desirable for theoretically reducing the possibility of stent thrombosis.
conceived and developed in Brazil and has recently obtained approval from the National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária -Anvisa) for clinical use. Sirolimus is exclusively delivered from the abluminal surface, i.e., from the stent aspect facing the vessel wall, of biodegradable polymers and in pre-clinical studies with implantation of a previous version of this drug-eluting stent, with sirolimus being delivered from both the luminal (stent aspect facing the vessel lumen) and the abluminal stent aspect in the coronary arteries of pigs. This showed effective inhibition of neointimal proliferation 5 .
The presence of sirolimus only in abluminal stent aspect is theoretically more advantageous in relation to sirolimus-eluting stents in the luminal and abluminal aspects for promoting faster stent endothelialization 6 .
The presence of bare-metal stent struts uncovered by endothelium is known to possibly have an important role in predisposition to the occurrence of late thrombosis [7] [8] [9] [10] . Therefore, in order to estimate the clinical safety of drug-eluting stents, it is important to estimate, in pre-clinical studies, the magnitude of stent endothelialization rates after their implantation 7, 8 .
The objective of the present study was to evaluate Scitech ® sirolimus-eluting stent strut endothelialization (with sirolimus
Introduction
Studies in laboratory animals are fundamental for a better understanding of the pathophysiology of cardiovascular diseases 1 . These essays enable the development of new diagnostic and therapeutic methods, in addition to the evaluation of the safety and efficacy of these methods before they are applied in humans 2 .
The introduction of coronary stents in the therapeutic armamentarium of interventional cardiology has resulted in remarkable advance in the treatment of coronary artery disease, especially after antiproliferative drugs have been added to these stents 3 .
The Inspiron® sirolimus-eluting stent (Scitech® Medical Products, Goiânia, Brazil) is based on a fine-strut chromiumcobalt (Cro-co) metallic-bond stent (Cronus ® stent) 4 . It was
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The right carotid artery of each animal was dissected, and a 4F vascular sheath was inserted within the artery under direct view. Through this sheath, unfractionated heparin 250 IU/kg was administered, and a 0.035" hydrophilic wire was directed toward the descending aorta under fluoroscopic guidance by means of Phillips BV Pulsera ® digital angiography equipment. A 4F-angiography catheter was then advanced up to the distal aorta. Nitroglycerin 200 µg was infused, followed by angiographic imaging of the distal descending aorta and iliac arteries. A 0.014" Choice ® PT guidewire (Boston Scientific Corporation) was then introduced through the lumen of the angiography catheter up to one of the iliac arteries. After removal of the catheter, a 2.5x14-mm pre-mounted stent was introduced over the guide and deployed in the iliac artery by inflating for 10 seconds at a mean pressure of 7 ATM, with a targeted balloon/artery ratio of 1.2:1. The operator was blinded to the type of stent implanted in the iliac arteries (right and left) of each animal.
A total of 20 stents (Innovatech Medical Ltda, São Paulo and Scitech ® Medical Products, Goiânia, Brazil) were implanted, of which four were uncovered Cro-Co stens, six were polymer-covered Cro-Co stents in the luminal and abluminal aspects, three were polymer-covered Cro-Co stents only in the abluminal aspect, four were sirolimus-eluting stents in the luminal and abluminal aspects, and three were sirolimus-eluting stents in the abluminal aspect only. After implantation, the vascular sheath was removed, the carotid artery was ligated, and prophylactic antibiotic therapy with intramuscular gentamicin and benzylpenicillin solution was administered.
The animal was then sent back to the vivarium and kept for four weeks under standard diet and ad libitum water. It would later be restudied by means of dissection of the left carotid artery and control angiography.
Euthanasia
The animal was euthanized after control angiography by means of an overdose of the anesthetic agent sodium pentobarbital, soon after heparinization at a dose of 250 IU/kg. Median laparotomy was then performed with exposure of the abdominal aorta and inferior vena cava; saline solution 0.9% was infused in situ via catheter through the abdominal aorta until the content of the sectioned inferior vena cava was a clear solution. Next, a modified Karnovsky's fixative solution containing paraformaldehyde 2.0% and glutaraldehyde 2.5% in sodium cacodylate buffer solution 0.1 M and pH = 7.4 was infused at 100 mmHg pressure for 30 minutes 9 .
Scanning electron microscopy
The iliac artery segment containing the stent was dissected, removed and bisected longitudinally; one of the halves was sent to pathological study and the other to specific processing and further analysis on a scanning electron microscope.
The half-segment containing the stent was immersed into modified Karnovsky's solution for 12 hours at 4°C, washed in sodium cacodylate buffer solution, post-fixed in osmium tetraoxide 1% buffer solution and dehidrated in titrated alcohol up to absolute alcohol. The specimens were dried to the critical point in a Balzers CPD 030 device, then metalized with gold ions in a Balzers SCD 040 device, and analyzed in a JSM 7401S (JEOL, Japan) scanning electron microscope with 25x magnification. The images obtained were filed and analyzed by means of the Adobe ® Photoshop ® version 7.0 (Adobe Systems Inc.) and ImageJ version 1.42q for Windows (NIH, Bethesda, USA) software programs; the areas of exposed stent strut were measured (mm 2 ), and the percentages of endothelialization (%) for each type of stent were calculated.
Statistical analysis
Data are described as means ± SD or numbers (percentages).
Comparison of the means between the types of stents was made using one-way analysis of variance (One-way ANOVA). If the variance ratio test (F test) were significant, the post-hoc analysis of the difference of the means between the groups would be made using the Dunnett's test. The significance level was set at 5% (α). The IBM ® SPSS ® Statistics version 20 statistical program was used for data analysis.
Results
All 10 rabbits initially survived the procedure of stent implantation, and none of them developed any neurological deficit as a result of the carotid artery ligation. which two polymer-coated stents only in the abluminal aspect had been implanted, was found dead (undetermined cause of death) in the 3rd week post stent implantation. This resulted in an insufficient sample size for the analysis of endothelialization of polymer-coated stents only in the abluminal aspect, and data regarding the other stent of the same type (polymercoated stent only in the abluminal aspect) implanted in the left iliac artery of rabbit 7 were excluded (Table 1) .
Control angiography
All stents were patent and without angiographic restenosis or image suggestive of thrombus at the moment of the restudy after four weeks of stent implantation.
Scanning electron microscopy
The areas analyzed (mean ± SD) measured 17.03 ± 4.82; 15.89 ± 3.90; 17.97 ± 3.25 and 10.40 ± 4.54 regarding the uncoated stent, polymer-coated stent in the luminal and abluminal aspects, sirolimus-eluting stent in luminal and abluminal aspects and sirolimus-eluting stent in the abluminal aspect only, respectively (p = 0.219).
The areas of stent strut exposed (mean ± SD) (mm 2 ) were 0.12 ± 0.08; 0.09 ± 0.12; 0.60 ± 0.67 and 0.05 ± 0.04 (uncoated stent, polymer-coated stent in the luminal and abluminal aspects, sirolimus-eluting stent in luminal and abluminal aspects and sirolimus-eluting stent in the abluminal aspect only, respectively) (p = 0.120).
Percentages of endothelialization were 99%; 99%; 97% and 99% (uncoated stent, polymer-coated stent in the luminal and abluminal aspects, sirolimus-eluting stent in luminal and abluminal aspects and sirolimus-eluting stent in the abluminal aspect only, respectively) (p = 0.133) ( Table 2 and Figure 1 ).
Discussion
The results of this study showed that sirolimus-eluting stents in the luminal and abluminal aspects and exclusively in Table 1 abluminal aspect had a rate of stent-strut endothelialization similar to that found in non-eluting stents after four weeks of implantation in the iliac arteries of non-atherosclerotic rabbits.
Several coronary stents eluted in antiproliferative drugs showed effective inhibition of neointimal proliferation and reduction of restenosis rates, as well as the need for target-vessel reintervention. One of the concerns related to the use of these drug stents is the probability, albeit rare, of the occurrence of late thrombosis 8 . Fast post-implantation endothelialization of drug stents is a desirable phenomenon for theoretically reducing the risk of both early and late thrombosis 10 .
P r e -c l i n i c a l e v a l u a t i o n o f p o s t -i m p l a n t a t i o n reendothelialization of drug stents is preferably made by implanting these stents in the iliac arteries of rabbits, since the results obtained with these animals are the ones that are most similar to those observed in humans 11 . The coronary arteries of pigs reendothelialize very quickly after stent implantation and are more useful for the assessment of implant safety. Additionally, pre-clinical studies with stent implantation in animals with induced atherosclerosis are currently recommended 12, 13 . When endothelialization data from Inspiron ® sirolimuseluting stents (Scitech ® , Goiânia, Brazil) are compared to the experimental data from Joner et al's study 14 as regards stent strut endothelialization, we verify that the Inspiron ® stent endothelialization rate (99%) is higher than that of other drug stents (Cypher ® : 64%, Taxus ® : 68%, Endeavor ® : 76% and Xience V ® : 80%) for the same observation period of four weeks post-implantation. This difference may result from the sirolimus elution only in the abluminal aspect in the Inspiron ® stent, whereas the antiproliferative drugs are released from both stent aspects in the other stents. Another factor that could explain this difference is that we did not perform denudation prior to the stent implantation, thus minimizing the occurrence of arterial spasm, trauma, and arterial dissection. Thus, using this methodology, we could only analyze endothelialization on the stent struts, but not between the stent struts. Another methodological difference of our study in relation to Joner et al's study 14 is that we used the carotid approach whereas they used the femoral approach. The use of the femoral approach with artery ligation at the end of stent implantation in iliac arteries may cause the arterial flow to slow down upstream from the ligation point, and this would theoretically have an impact on several aspects of coagulation and possibly on stent endothelialization; for this reason we chose the carotid approach 15 .
Study limitations
Non-atherosclerotic animals were used in the present study. However, because of the atherosclerotic process specificities (multifactorial, chronic disease), an animal model with atherosclerosis reliably reproducing this abnormality as seen in humans has not yet been developed.
The observation period post-stent implantation in iliac arteries of rabbits was 30 days. We observed low standarddeviations (minimum of 0 and maximum of 0.03) for the rates of endothelialization on the stent struts studied; thus, by using a test power of 80% and admitting a beta error of 5%, we calculated that the sample number for each type of stent was sufficient, except for the group of polymer-coated stents in the abluminal aspect, which was removed from this comparative analysis. However, groups of additional animals could have been studied for shorter observation periods (seven and/or 14 days), but this was not the object of this initial investigation.
The functional aspects of the neointima recovering the stent struts after four weeks of implantation were not assessed in the present study. 
Conclusion
After four weeks of implantation in the iliac arteries of rabbits, the drug stents releasing sirolimus from the luminal and abluminal aspects and abluminal aspect only showed almost complete endothelialization on struts (97% to 99%) with no statistically difference from endothelialization occurring in non-drug eluting stents (uncoated stents and polymer-coated stents in the luminal and abluminal aspects) (99%).
